Nitroglycerin (NTG)

DRUG4 trials

Sponsors

Bristol-Myers Squibb, Muhammad Aamir Latif, Copenhagen University Hospital, Hvidovre, National Cheng-Kung University Hospital

Conditions

Acute Heart Failure (AHF)Cardiac FailureCoronary Artery Bypass GraftingHeart FailurePancreatitisReduced Ventricular Ejection Fraction

Phase 2

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

CompletedNCT03357731

Bristol-Myers SquibbCardiac Failure, Heart Failure, Reduced Ventricular Ejection Fraction

Start: 2017-11-30End: 2019-05-10Updated: 2020-07-27

Phase 4

Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure

CompletedNCT06682260

Copenhagen University Hospital, HvidovreAcute Heart Failure (AHF)

Start: 2025-02-01End: 2025-11-30Updated: 2026-03-18

Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis

RecruitingNCT07083063

National Cheng-Kung University HospitalPancreatitis

Start: 2025-09-15End: 2027-07-31Target: 440Updated: 2025-12-08

Unknown Phase

The Effect of Intranasally Administered Nitroglycerin on Hemodynamic Response to Laryngoscopy and Intubation Among Patients Undergoing Coronary Artery Bypass Grafting (CABG) Surgery

CompletedNCT06637956

Muhammad Aamir LatifCoronary Artery Bypass Grafting

Start: 2024-01-01End: 2024-06-30Updated: 2024-10-15